Wright Medical Group, Inc. (NASDAQ:WMGI) – Research analysts at Oppenheimer reduced their Q4 2018 EPS estimates for Wright Medical Group in a report issued on Thursday, May 10th. Oppenheimer analyst S. Lichtman now anticipates that the medical device company will earn $0.09 per share for the quarter, down from their prior estimate of $0.11. Oppenheimer currently has a “Hold” rating and a $25.00 target price on the stock.
Wright Medical Group (NASDAQ:WMGI) last released its earnings results on Wednesday, May 9th. The medical device company reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.06. The business had revenue of $198.54 million during the quarter, compared to the consensus estimate of $193.69 million. Wright Medical Group had a negative net margin of 22.11% and a negative return on equity of 2.58%. The company’s revenue for the quarter was up 12.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.09) EPS.
NASDAQ:WMGI opened at $23.85 on Monday. The company has a market cap of $2.52 billion, a price-to-earnings ratio of -108.41 and a beta of 0.67. The company has a debt-to-equity ratio of 1.46, a current ratio of 1.42 and a quick ratio of 0.95. Wright Medical Group has a fifty-two week low of $23.46 and a fifty-two week high of $24.17.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Swiss National Bank increased its holdings in Wright Medical Group by 1.9% in the 4th quarter. Swiss National Bank now owns 167,094 shares of the medical device company’s stock worth $3,709,000 after acquiring an additional 3,100 shares during the last quarter. Comgest Global Investors S.A.S. purchased a new position in Wright Medical Group during the 4th quarter valued at about $1,991,000. Iguana Healthcare Management LLC purchased a new position in Wright Medical Group during the 4th quarter valued at about $444,000. Peregrine Capital Management LLC grew its holdings in Wright Medical Group by 0.6% during the 4th quarter. Peregrine Capital Management LLC now owns 988,636 shares of the medical device company’s stock valued at $21,948,000 after buying an additional 6,202 shares in the last quarter. Finally, Endurant Capital Management LP grew its holdings in Wright Medical Group by 670.7% during the 4th quarter. Endurant Capital Management LP now owns 305,200 shares of the medical device company’s stock valued at $6,775,000 after buying an additional 265,600 shares in the last quarter.
Wright Medical Group Company Profile
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.
Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.